Polar Asset Management Partners’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-159,800	Closed	-$548K	–	660
2025 Q2	$548K	Buy	+159,800	New	+$398K	0.01%	405
2025 Q1	–	Sell	-117,830	Closed	-$345K	–	531
2024 Q4	$345K	Hold	117,830	–	–	0.01%	481
2024 Q3	$306K	Hold	117,830	–	–	0.01%	477
2024 Q2	$349K	Hold	117,830	–	–	0.01%	441
2024 Q1	$534K	Hold	117,830	–	–	0.01%	462
2023 Q4	$673K	Hold	117,830	–	–	0.02%	450
2023 Q3	$542K	Hold	117,830	–	–	0.01%	492
2023 Q2	$761K	Hold	117,830	–	–	0.02%	536
2023 Q1	$888K	Hold	117,830	–	–	0.02%	589
2022 Q4	$1.19M	Hold	117,830	–	–	0.02%	672
2022 Q3	$1.17M	Hold	117,830	–	–	0.02%	752
2022 Q2	$1.25M	Sell	117,830 -510,300	-81%	-$4.32M	0.02%	737
2022 Q1	$6.12M	Buy	+628,130	New	+$5.95M	0.08%	357
2021 Q4	–	Sell	-25,000	Closed	-$501K	–	1296
2021 Q3	$501K	Sell	25,000 -30,000	-55%	-$530K	0.01%	840
2021 Q2	$1.21M	Buy	55,000 +15,000	+38%	+$414K	0.01%	604
2021 Q1	$1.36M	Sell	40,000 -135,000	-77%	-$5.38M	0.02%	522
2020 Q4	$7.04M	Buy	+175,000	New	+$8M	0.13%	241